| Getting to Know Virtual Consultations | 2023-04-20 | 17:00–18:00 | | | | |
| Designing and conducting clinical trials in rare disease-what industries expect for partnering with clinical sites | 2023-04-14 | 12:30–13:30 | Diego Ardigò | | | |
| MTG7 | Genetic diagnosis of azoospermia: from chromosomes to whole exome analysis | 2023-03-30 | 17:00–18:00 | | | | |
| Getting to Know Rare Disease Registries | 2023-03-22 | 16:00–17:00 | | | | |
| 5-year Evaluation Q&A Sessions | 2023-02-15 | 17:00–18:00 | | | | |
| MTG5MTG6 | Craniopharyngioma and hypothalamic obesity | 2023-01-31 | 16:00–17:30 | H.W. Gan, Hanneke M. van Santen, Johan De Graaf and Sebastian J.C.M.M. Neggers | | | |
| A tool to help patients with rare endocrine diseases | 2022-12-14 | 17:00–18:30 | Susan M Webb, Matt Bolz-Johnson, Lenja Wiehe, Jette Kristensen, Anna Nordenström and Diana Vitali | | | |
| MTG4 | MEN-1 – a joint webinar from ESE, Endo-ERN and ESPE | 2022-11-29 | 17:00–19:00 | Gregory Kaltsas (Greece), Gerlof Valk (Netherlands) and Carla Pieterman (Netherlands) | | | |
| EURORDIS webinar series on Clinical Practice Guidelines – November 14 and 24 | 2022-11-14 | 17:00–19:00 | | | | |
| ERDRI.spider training (on-line) | 2022-11-01 | 17:00–19:00 | | | | |
| MTG8 | For a prolonged use of antithyroid drug in children with Graves’disease | 2022-09-29 | 17:00–18:00 | Juliane Léger and Edward Visser | | | |
| ePAG Exchange of Good Practices – VASCERN Flowchart webinar | 2022-09-27 | 16:00–17:30 | | | | |
| MTG8 | The challenging diagnosis of TSH-omas and RTHbeta – a case-based discussion | 2022-07-04 | 16:00–17:00 | Luca Persani and Irene Campi | | | |
| A joint webinar from ESE, Endo-ERN and ESPE | 2022-06-28 | 16:30–18:00 | | | | |
| MTG5 | Noonan syndrome with emphasis on current guidelines regarding growth, endocrinology and growth hormone therapy | 2022-06-07 | 17:00–18:00 | Jovanna Dahlgren and Kees Noordam | | | |
| MTG5 | New growth treatments for Achondroplasia | 2022-05-10 | 16:00–17:00 | Klaus Mohnike, Jean Pierre Salles and Patricia Carl | | | |
| CPMS Training workshop | 2022-04-08 | 10:00–12:00 | | | | |
| EMA: Repurposing of authorised medicines: pilot to support not-for-profit organisations and academia | 2022-02-17 | 10:00–12:00 | | | | |
| Webinar ETA guideline pediatric thyroid nodules and thyroid carcinoma | 2021-12-15 | 19:00–20:30 | | | | |
| MTG8 | 80 years of radioiodine – what’s new? | 2021-12-01 | 15:00–16:00 | Erik Verburg | | | |
| MTG8 | Challenges in the management of non-metastatic thyroid carcinoma | 2021-11-25 | 15:00–17:00 | Barbara Jarzab, Jolanta Krajewska, Dagmara Rusinek, Daria Handkiewicz-Junak, Ewa Chmielik and Agnieszka Czarniecka | | | |
| MTG5 | Growth & Genetic Obesity Syndromes – Prader Willi Syndrome (PWS) Clinical management of transition of care | 2021-11-16 | 14:00–17:00 | Maithe Tauber, Tony Holland , Laura de Graaff, Charlotte Höybye, Christine Poitou and Berit Otterlei | | | |
| MTG7 | Update on the management of 46,XX Ovarian Dysgenesis and Primary Ovarian Insufficiency | 2021-09-09 | 15:00–16:00 | Philippe Touraine | | | |
| MTG5 | Overgrowth syndromes Beckwith Wiedemann syndrome and other rare conditions | 2021-09-07 | 17:00–18:00 | Frédéric Brioude | | | |
| 8th International Disorders/Differences of Sex Development Symposium | 2021-07-08 | 17:00–18:00 | | | | |
| MTG3 | Update on congenital hyperinsulinism | 2021-07-06 | 16:00–17:00 | Oliver Blankenstein, Peter Kühnen, Sebastian Kummer, Thomas Meissner and Alena Welters | | | |
| EuRR-Bone What and how?” | 2021-06-28 | 17:00–18:00 | Natasha Appelman-Dijkstra and Ana Priego Zurita | | | |
| hPSCreg | 2021-06-21 | 15:00–16:00 | Nancy Mah | | | |
| MTG5 | Clinical trials with new drugs in PWS | 2021-06-15 | 17:00–18:00 | Maithe Tauber | | | |
| MTG1 | Clinical and genetic aspects of pheochromocytoma | 2021-06-14 | 15:00–16:00 | Peter Igaz | | | |
| MTG3 | Rare diabetes caused by endoplasmic reticulum stress – clinical features and novel patients’ stem cell-based models | 2021-05-26 | 16:00–17:00 | Miriam Cnop | | | |
| MTG6 | Central congenital hypothyroidism; clinical characteristics and cognitive outcome in early detected patients | 2021-05-12 | 14:00–15:00 | Nitash Zwaveling-Soonawala, Paul van Trotsenburg, Jolanda Naafs and Anita Boelen | | | |
| MTG6 | Pituitary Gigantism FIPA, AIP and XLAG | 2021-04-22 | 16:00–17:00 | Adrian F. Daly and Albert Beckers | | | |
| MTG6 | Development and integration of VBHC in pituitary care in an Endo-ERN reference center | 2021-04-19 | 17:00–18:00 | Nienke Biermasz and Friso de Vries | | | |
| MTG5 | Molecular diagnostic testing of imprinting disorders and related growth disturbances | 2021-03-02 | 17:00–18:00 | Thomas Eggermann | | | |
| How to enroll a patient, start a panel and upload files to a panel | 2021-02-23 | 17:00–17:30 | Danielle Steenvoorden | | | |
| How to invite members to your panel, schedule a video meeting and join a video meeting | 2021-01-28 | 17:00–17:30 | Danielle Steenvoorden | | | |
| MTG2 | Endocrine and bone management in Duchenne muscular dystrophy | 2021-01-25 | 14:30–15:30 | Jarod Wong and Justus Kuijer | | | |
| MTG7 | Sex Development & Maturation | 2020-12-18 | 13:00–15:00 | Olaf Hiort, Luca Persani, Manuela Brösamle, Arlene Smyth, Sasha Howard, Martine Cools, Guy T'Sjoen, Anders Juul and Anna Nordenström | | | |
| MTG2 | Hypophosphatasia – Diagnosis and Management | 2020-12-08 | 18:00–19:30 | Faisal Ahmed, James Irvine, Agnès Linglart and Anya Rothenbuller | | | |
| How to enrol a patient, start a panel and upload files to a panel | 2020-12-03 | 17:00–18:00 | Danielle Steenvoorden and Isabel Moenig | | | |
| MTG5 | Diagnosis and management of Silver–Russell Syndrome, a multidisciplinary care is necessary | 2020-11-24 | 17:00–18:00 | Irene Netchine | | | |
| MTG3 | Wolfram syndrome – Diagnostics, Biomarkers, and Therapeutic Options | 2020-11-11 | 15:00–16:00 | Fumihiko Urano | | | |
| MTG3 | Wolfram syndrome | 2020-10-07 | 15:00–16:00 | Timothy Barrett | | | |
| MTG5 | Prader-willi syndrome | 2020-09-29 | 17:00–18:00 | Anita Hokken | | | |
| MTG3 | Monogenic insulin resistance – diagnosis, treatment, and insights for common disease | 2020-09-16 | 15:00–16:00 | Robert K. Semple | | | |
| MTG3 | Understanding Lipodystrophy | 2020-07-08 | 15:00–16:00 | Giovanni Ceccarini and Rebecca Sanders | | | |
| MTG5 | Genetic Obesity Disorders caused by Leptin-melanocortin Pathway Defects | 2020-07-07 | 18:00–19:00 | Erica van den Akker | | | |
| MTG8 | Update on the consensus on congenital hypothyroidism a patient centered approach | 2020-07-01 | 18:00–19:00 | Michel Polak | | | |
| COVID-19 Endocrine conditions with increased risk – Endo-ERN | 2020-05-12 | 18:00–19:00 | Alberto Pereira, Eelco de Koning and Wiebke Artl | | | |
| MTG1 | Update on congenital adrenal hyperplasia | 2020-03-23 | 18:00–19:00 | Nicole Reisch | | | |
| MTG4 | Prophylactic thyroidectomy in Children with MEN2 | 2020-02-21 | 18:00–19:00 | Tom Kurzawinski | | | |
| MTG7 | Turner Syndrome Guideline & the patient perspective | 2020-02-13 | 18:00–19:00 | Claus H. Gravholt and Arlene Smyth | | | |
| MTG3 | Alström Syndrome | 2019-11-25 | 15:00–16:00 | Pietro Maffei | | | |
| MTG3 | Hyperinsulinism | 2019-07-01 | 10:00–11:00 | Klaus Mohnike and Indi Banerjee | | | |
| MTG2 | Hypoparathyroidism in adults, diagnosis and therapeutic challenges | 2019-02-28 | 14:00–14:30 | Lars Rejnmark | | | |